US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about #covid/19

Recent news which mentions #covid/19

The Path to Job Mobility
Tickers MA
Tags future of work #careers mastercard
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, in the New England Journal of Medicine
Tickers MRK
Tags Innovation & Technology Merck & Co Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News